<qa>  What is the clinical setting for the multicenter phase II trial?This multicenter phase II trial is designed to study the unique combination of chemotherapy irinotecan.carboplatin and bevacizumab in the extensive-stage setting. This clinical setting seems ideal for evaluation of the role of bevacizumab in delaying progression and prolonging survival. 